Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13 - PubMed (original) (raw)
Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13
A Toren et al. Am J Hum Genet. 1999 Dec.
Abstract
Fechtner syndrome is an autosomal-dominant variant of Alport syndrome, manifested by nephritis, sensorineural hearing loss, cataract formation, macrothrombocytopenia, and polymorphonuclear inclusion bodies. As opposed to autosomal-recessive and X-linked Alport syndromes, which have been genetically well studied, the genetic basis of Fechtner syndrome remains elusive. We have mapped the disease-causing gene to the long arm of chromosome 22 in an extended Israeli family with Fechtner syndrome plus impaired liver functions and hypercholesterolemia in some individuals. Six markers from chromosome 22q yielded a LOD score >3.00. A maximum two-point LOD score of 7.02 was obtained with the marker D22S283 at a recombination fraction of 0. Recombination analysis placed the disease-causing gene in a 5.5-Mb interval between the markers D22S284 and D22S1167. No collagen genes or genes comprising the basement membrane have been mapped to this region.
Figures
Figure 1
Pedigree and typing for eight chromosome 22 markers. Circles represent females, and squares represent males; unblackened symbols denote unaffected individuals, and blackened symbols denote affected individuals. Critical recombinations in individuals II-5, III-5, III-11, IV-3, and IV-7 define a 4-2-4-4-2-5 haplotype that is coinherited with the disease and that is not shared by the unaffected family members.
Figure 2
Schematic map of the interval containing the disease gene on chromosome 22. The markers are illustrated on the right.
Similar articles
- Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. Heath KE, et al. Am J Hum Genet. 2001 Nov;69(5):1033-45. doi: 10.1086/324267. Epub 2001 Oct 4. Am J Hum Genet. 2001. PMID: 11590545 Free PMC article. - Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13.
Toren A, Rozenfeld-Granot G, Rocca B, Epstein CJ, Amariglio N, Laghi F, Landolfi R, Brok-Simoni F, Carlsson LE, Rechavi G, Greinacher A. Toren A, et al. Blood. 2000 Nov 15;96(10):3447-51. Blood. 2000. PMID: 11071640 - Localisation of the gene responsible for fechtner syndrome in a region <600 Kb on 22q11-q13.
Cusano R, Gangarossa S, Forabosco P, Caridi G, Ghiggeri GM, Russo G, Iolascon A, Ravazzolo R, Seri M. Cusano R, et al. Eur J Hum Genet. 2000 Nov;8(11):895-9. doi: 10.1038/sj.ejhg.5200533. Eur J Hum Genet. 2000. PMID: 11093280 - [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S. Kunishima S. Rinsho Byori. 2009 Apr;57(4):365-70. Rinsho Byori. 2009. PMID: 19489439 Review. Japanese. - Familial hematuric syndromes--Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes.
Kashtan CE. Kashtan CE. Contrib Nephrol. 2001;(136):79-99. doi: 10.1159/000060181. Contrib Nephrol. 2001. PMID: 11688406 Review. No abstract available.
Cited by
- Molecular and genetic basis of inherited nephrotic syndrome.
Gigante M, Piemontese M, Gesualdo L, Iolascon A, Aucella F. Gigante M, et al. Int J Nephrol. 2011;2011:792195. doi: 10.4061/2011/792195. Epub 2011 Sep 6. Int J Nephrol. 2011. PMID: 21904677 Free PMC article. - Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.
Pecci A, Biino G, Fierro T, Bozzi V, Mezzasoma A, Noris P, Ramenghi U, Loffredo G, Fabris F, Momi S, Magrini U, Pirastu M, Savoia A, Balduini C, Gresele P; Italian Registry for MYH9-releated diseases. Pecci A, et al. PLoS One. 2012;7(4):e35986. doi: 10.1371/journal.pone.0035986. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558294 Free PMC article. - Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. Heath KE, et al. Am J Hum Genet. 2001 Nov;69(5):1033-45. doi: 10.1086/324267. Epub 2001 Oct 4. Am J Hum Genet. 2001. PMID: 11590545 Free PMC article. - The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.
Martignetti JA, Heath KE, Harris J, Bizzaro N, Savoia A, Balduini CL, Desnick RJ. Martignetti JA, et al. Am J Hum Genet. 2000 Apr;66(4):1449-54. doi: 10.1086/302873. Epub 2000 Mar 17. Am J Hum Genet. 2000. PMID: 10739770 Free PMC article.
References
Electronic-Database Information
- Genome Database, http://gdbwww.gdb.org (for markers for microsatellite studies)
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim (for Alport syndrome [MIM <153640>], Fechtner syndrome [MIM <153640>], Epstein syndrome [MIM153650], and Bernard-Soulier syndrome [MIM <231200>.0001])
References
- Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschenes G, Gros F, et al (1992) Alport syndrome and diffuse leiomyomatosis: deletions in the 5′ end of the COL4A5 gene. Kidney Int 42:1178–1183 - PubMed
- Bernheim J, Dechavanne M, Byron PA, Lagards M, Colon S, Pozet N, Traeger J (1976) Thrombocytopenia, macrothrombopathia, nephritis and deafness. Am J Med 61:145–150 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous